ADMA Biologics Inc (ADMA) Social Stream



ADMA Biologics Inc (ADMA): $6.20

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add ADMA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#92 of 362

in industry

ADMA BIOLOGICS INC (ADMA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ADMA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 5 $10 $3 $5.7 $4.4 29.55%
2021-11-11 5 $10 $3 $5.7 $4.4 29.55%
2022-01-06 4 $10.001 $3 $5.7 $4.4 29.55%
2022-03-24 4 $8 $3 $5.3 $4.4 20.45%
2022-03-28 3 $8 $3 $5.3 $4.4 20.45%
2022-05-12 2 $6 $3 $4.625 $4.4 5.11%
2022-07-25 3 $5 $4 $4.5 $4.4 2.27%
2022-08-11 3 $5 $4 $4.666 $4.4 6.05%
2022-10-13 4 $5 $4 $4.75 $4.4 7.95%
2022-11-11 3 $6 $4 $5 $4.4 13.64%
2022-12-12 4 $6 $4 $5 $4.4 13.64%
2023-07-11 4 $6 $4.5 $5.166 $4.4 17.41%
2023-07-18 4 $6 $4.5 $5.125 $4.4 16.48%
2023-08-10 4 $7 $5 $5.75 $4.4 30.68%
2023-11-10 4 $7 $5 $6 $4.4 36.36%

The Trend in the Analyst Price Target


Over the past 20 months, ADMA's average price target has gone up $1.38.

Over the past 42 weeks, ADMA's average upside potential has been 45.96%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-07-11 4 6 4.5 5.125 3.55 44.37%
2023-07-11 4 6 4.5 5.166 3.55 45.52%
2023-07-18 4 6 4.5 5.125 3.57 43.56%
2023-08-10 4 7 5.0 6.000 4.31 39.21%
2023-08-10 4 7 5.0 5.750 4.31 33.41%

ADMA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


ADMA's average broker recommendation rating improved by 0 over the prior 15 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADMA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, ADMA BIOLOGICS INC's average analyst price target is greater than 59.38% of them.
  • In terms of how ADMA BIOLOGICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 159.53% of that group.
  • ADMA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is higher than 297.04% of Pharmaceutical Products stocks.
  • In terms of how ADMA BIOLOGICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -385.7% of that group.

Stocks similar to ADMA BIOLOGICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VXRT, PSTX, and TARS.

Make investment decisions regarding ADMA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!